4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-055844
Chief Executive Officer sold 6,000 shares at $66.76 ($400,560)
- Chief Executive Officer acquired 6,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schenkein David P Chief Executive Officer | 2017-10-02 | Option exercise | +6,000 | $0.30 | $1,815 | 6,000 | D |
| Schenkein David P Chief Executive Officer | 2017-10-02 | Sale | −6,000 | $66.76 | $400,560 | 0 | D |
| Derivatives | |||||||
| Schenkein David P Chief Executive Officer | 2017-10-02 | Option exercise · Stock option (right to buy) | −6,000 | 112,656 | D | ||
| Open-market sales · 6,000 sh · avg $66.76 · $400,560 | |||||||
Loading xslF345X03/doc4.xml…